GO:0052742 phosphatidylinositol kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052742 phosphatidylinositol kinase activity is defined as catalysis of the reaction ATP + a phosphatidylinositol = ADP + a phosphatidylinositol phosphate.
• This activity is carried out by lipid kinases such as PI3K and PIP5K, which phosphorylate the inositol ring of phosphatidylinositol lipids [1,2].
• Phosphatidylinositol kinase activity is central to signal transduction, membrane trafficking, and cell growth control [1,3].
• Insulin and growth factor receptors recruit and activate phosphatidylinositol kinase activity, linking it to metabolic regulation [4,5,7].
• Dysregulated phosphatidylinositol kinase activity contributes to cancer, metabolic disorders, and host-pathogen interactions [1,6,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of phosphatidylinositol kinase function in cells [1,2].
Description
Phosphatidylinositol kinase activity (GO:0052742) is a molecular function that catalyzes the transfer of a phosphate group from ATP to a phosphatidylinositol lipid, producing ADP and a phosphatidylinositol phosphate. This reaction is fundamental to the generation of phosphoinositide signaling molecules that regulate diverse cellular processes, including proliferation, survival, vesicle trafficking, and cytoskeletal dynamics [1,3]. The activity was first associated with oncogenic transformation by polyoma middle-T antigen, establishing a link between lipid phosphorylation and cancer. Subsequent studies identified phosphatidylinositol kinase activity in complex with the insulin receptor, demonstrating its role in metabolic signaling. Today, researchers study this activity to understand how cells decode extracellular cues and how its dysregulation leads to disease [1,8]. The availability of CRISPR-based models has made it possible to precisely manipulate genes encoding phosphatidylinositol kinases and their regulators, accelerating functional discovery.
phosphatidylinositol kinase activity At A Glance
| GO ID | GO:0052742 |
|---|---|
| GO term | phosphatidylinositol kinase activity |
| Ontology | molecular_function |
| Synonym | 1-phosphatidylinositol kinase activity |
| Definition | Catalysis of the reaction: ATP + a phosphatidylinositol = ADP + a phosphatidylinositol phosphate. |
| Major function | Phosphorylation of phosphatidylinositol lipids to generate phosphoinositide signaling molecules. |
| Representative enzymes | PI3K, PIP5K, and related lipid kinases [1,2]. |
| Associated processes | Signal transduction, membrane trafficking, cell growth, and metabolism [1,3,4]. |
What Is GO:0052742?
According to the Gene Ontology, phosphatidylinositol kinase activity (GO:0052742) is the catalysis of the reaction: ATP + a phosphatidylinositol = ADP + a phosphatidylinositol phosphate. In other words, it is the enzymatic addition of a phosphate group to the inositol headgroup of phosphatidylinositol, generating a phosphorylated lipid product. This activity is synonymous with 1-phosphatidylinositol kinase activity and is classified under molecular_function.
Why Is phosphatidylinositol kinase activity Important in Cell Biology?
Phosphatidylinositol kinase activity is essential for converting extracellular signals into intracellular responses through the production of phosphoinositide second messengers. Its dysregulation is implicated in cancer, diabetes, and infectious diseases, making it a major target for therapeutic intervention and a focus of basic and translational research [1,6,8].
• Generates phosphoinositide signaling lipids that control cell proliferation and survival.
• Links growth factor and insulin receptor signaling to downstream metabolic effects [4,5,7].
• Plays a role in oncogenic transformation, as shown for polyoma middle-T antigen.
• Contributes to membrane trafficking and cytoskeletal reorganization [1,2].
• Is exploited by pathogens such as Trypanosoma cruzi for their own lipid signaling.
• Serves as a target for drug discovery in cancer and metabolic diseases [1,8].
• Enables researchers to study lipid signaling with genetic precision using CRISPR.
• Provides a mechanistic basis for understanding insulin resistance and diabetes [4,5,7].
• Involved in negative feedback regulation of receptor signaling.
• Offers a model system for studying enzyme kinetics and membrane interactions.
Molecular Mechanism of phosphatidylinositol kinase activity
Substrate recognition and binding
In simple terms: The enzyme grabs the lipid substrate in the membrane.
Phosphatidylinositol kinases bind phosphatidylinositol lipids embedded in cellular membranes. The enzyme active site recognizes the inositol headgroup, positioning it for phosphorylation. Membrane interaction is often mediated by specific domains that target the kinase to appropriate compartments.
Catalytic transfer of phosphate
In simple terms: The enzyme moves a phosphate from ATP onto the lipid.
The catalytic mechanism involves transfer of the gamma-phosphate of ATP to the 3-OH, 4-OH, or 5-OH position of the inositol ring, depending on the enzyme class. This produces ADP and a phosphatidylinositol phosphate. For example, PI3K phosphorylates the 3-position, while PIP5K phosphorylates the 5-position [1,2].
Cofactors and metal ions
In simple terms: Metal ions help the enzyme work.
Many phosphatidylinositol kinases require magnesium or manganese ions for catalysis. These ions stabilize ATP and facilitate the phosphoryl transfer reaction. The exact metal dependence can vary among family members.
Regulation by dimerization and membrane environment
In simple terms: The enzyme can be switched on by coming together or by its membrane surroundings.
Membrane-mediated dimerization potentiates PIP5K lipid kinase activity, showing that the lipid environment and protein-protein interactions regulate catalysis. Receptor tyrosine kinases such as the insulin receptor recruit and activate phosphatidylinositol kinase activity upon ligand binding [4,5,7].
Negative regulation and feedback
In simple terms: The signal can be turned off by negative regulators.
Negative receptor signalling pathways attenuate phosphatidylinositol kinase activity to prevent excessive signaling. This feedback is critical for maintaining cellular homeostasis and preventing oncogenic transformation [1,8].
Key Genes Involved in GO:0052742 phosphatidylinositol kinase activity
The following genes encode enzymes or regulators directly associated with phosphatidylinositol kinase activity (GO:0052742) and are commonly studied in this context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIK3CA | Catalytic subunit of PI3K alpha; phosphorylates PI(4,5)P2 to PI(3,4,5)P3 | Frequently mutated in cancer; target for inhibitors |
| PIK3CB | Catalytic subunit of PI3K beta | Role in insulin signaling and metabolism [4,5] |
| PIK3CD | Catalytic subunit of PI3K delta | Immune cell signaling; immunodeficiency and lymphoma |
| PIK3CG | Catalytic subunit of PI3K gamma | Inflammation and immune responses |
| PIK3R1 | Regulatory subunit of PI3K | Mutations in cancer and insulin resistance [1,8] |
| PIP5K1A | Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha | Membrane trafficking and cytoskeleton |
| PIP5K1B | Phosphatidylinositol-4-phosphate 5-kinase type 1 beta | Vesicle trafficking |
| PIP5K1C | Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma | Focal adhesion and cell migration |
| PIP4K2A | Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | Phosphoinositide homeostasis |
| INPP4A | Inositol polyphosphate-4-phosphatase type I | Negative regulator of PI3K signaling |
| PTEN | Lipid phosphatase that opposes PI3K | Tumor suppressor; negative regulation |
| IRS1 | Insulin receptor substrate 1 | Links insulin receptor to PI3K activation [4,5] |
| INSR | Insulin receptor | Activates phosphatidylinositol kinase activity [4,5] |
| PDGFRA | Platelet-derived growth factor receptor alpha | Recruits PI3K to promote growth |
| EGFR | Epidermal growth factor receptor | Activates PI3K signaling |
| MTOR | mTOR kinase | Downstream effector and regulator of PI3K signaling |
| AKT1 | Serine/threonine kinase | Major downstream effector of PI3K |
| PTK2 | Focal adhesion kinase | Interacts with PIP5K in adhesion |
How Is phosphatidylinositol kinase activity Regulated?
Phosphatidylinositol kinase activity is regulated at multiple levels. Receptor tyrosine kinases such as the insulin receptor and EGFR recruit and activate PI3K upon ligand binding [4,5,7]. Membrane-mediated dimerization of PIP5K enhances its catalytic activity. Negative regulators including PTEN and INPP4A dephosphorylate phosphoinositides to terminate signaling. Additionally, feedback phosphorylation by downstream kinases such as AKT and mTOR modulates PI3K activity.
phosphatidylinositol kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIK3CA | Cancer (breast, colon, endometrial) | Knock-in of activating mutations in cell lines |
| PTEN | Cancer, Cowden syndrome | Knockout in cancer cell lines |
| INSR | Diabetes, insulin resistance | Point mutations in insulin receptor |
| PIK3CD | Immunodeficiency, lymphoma | Knockout in immune cells |
| PIP5K1C | Developmental disorders | Knockout in neuronal cells |
Cancer
Dysregulated phosphatidylinositol kinase activity is a hallmark of many cancers. Activating mutations in PIK3CA and loss of PTEN lead to constitutive PI3K signaling, promoting uncontrolled proliferation and survival [1,8]. The initial link between phosphatidylinositol kinase activity and oncogenic transformation was established with polyoma middle-T antigen.
Metabolic disorders
Insulin stimulates phosphatidylinositol-3-kinase activity in adipocytes, and defects in this pathway contribute to insulin resistance and type 2 diabetes [4,5,7]. Proper regulation of phosphatidylinositol kinase activity is essential for glucose homeostasis.
Infectious diseases
Pathogens such as Trypanosoma cruzi possess phosphatidylinositol kinase activities that are important for their life cycle, offering potential drug targets. Host phosphatidylinositol kinases can also be manipulated during infection.
Immune disorders
PI3K delta and gamma isoforms are critical for immune cell signaling, and their dysregulation leads to immunodeficiencies and autoimmune conditions. Negative receptor signalling pathways that attenuate phosphatidylinositol kinase activity are important for immune homeostasis.
From phosphatidylinositol kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PI3K alpha abolish phosphatidylinositol kinase activity? | PIK3CA knockout cell line |
| How do activating mutations affect kinase activity? | PIK3CA point mutation knock-in |
| What is the subcellular localization of PIP5K? | Tagged knock-in of PIP5K1A |
| Does overexpression of PTEN reduce phosphoinositide levels? | PTEN overexpression cell line |
| Which genes regulate phosphatidylinositol kinase activity? | CRISPR library screening |
| How does insulin stimulate phosphatidylinositol kinase activity? | INSR knockout adipocytes |
How to Study the phosphatidylinositol kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | Enzymatic activity of phosphatidylinositol kinases | Characterizing purified enzymes [1,4] |
| Lipidomics (LC-MS) | Levels of phosphatidylinositol phosphates | Profiling cellular phosphoinositides |
| CRISPR knockout screening | Genes required for phosphatidylinositol kinase activity | Identifying regulators |
| Immunoprecipitation | Protein complexes containing phosphatidylinositol kinase activity | Studying receptor association [3,4] |
| Fluorescence microscopy | Subcellular localization of kinases | Membrane targeting |
| Western blot | Expression and phosphorylation of pathway components | Signaling studies [5,7] |
| RNA-seq | Transcriptional changes upon pathway modulation | Global gene expression |
| Proteomics | Protein interactions and post-translational modifications | Mapping signaling networks |
Lipid kinase assays
In vitro kinase assays using radioactive ATP and phosphatidylinositol substrates measure the catalytic activity of immunoprecipitated or recombinant enzymes [1,4]. These assays are foundational for characterizing phosphatidylinositol kinase activity.
Phosphoinositide profiling by mass spectrometry
Mass spectrometry-based lipidomics quantifies phosphatidylinositol phosphate species in cells, providing a readout of phosphatidylinositol kinase activity in vivo [1,2].
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate phosphatidylinositol kinase activity or phosphoinositide levels, linking genotype to lipid signaling.
Live-cell imaging
Fluorescent biosensors and tagged proteins enable real-time visualization of phosphatidylinositol kinase localization and activity at membranes.
How CRISPR Can Be Used to Study GO:0052742 phosphatidylinositol kinase activity
Knockout
CRISPR knockout of genes encoding phosphatidylinositol kinases (e.g., PIK3CA, PIP5K1A) eliminates their activity, allowing researchers to assess loss-of-function phenotypes in cell proliferation, signaling, and lipid composition [1,2].
Point Mutation
Introducing specific point mutations (e.g., kinase-dead or activating mutations) via CRISPR base editing or HDR enables precise dissection of catalytic residues and regulatory phosphorylation sites in phosphatidylinositol kinases.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous loci allows visualization and purification of phosphatidylinositol kinases without overexpression artifacts, facilitating localization and interaction studies.
Overexpression
CRISPR activation or cDNA overexpression of phosphatidylinositol kinases and their regulators (e.g., PTEN) can amplify or suppress phosphoinositide signaling, useful for gain-of-function studies and drug testing [1,8].
How EDITGENE Supports phosphatidylinositol kinase activity Research
Researchers studying phosphatidylinositol kinase activity-related genes often need to determine whether a candidate gene is causally involved in lipid signaling, cell growth, or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol kinase activity research.
Frequently Asked Questions About phosphatidylinositol kinase activity
What is phosphatidylinositol kinase activity?
Phosphatidylinositol kinase activity (GO:0052742) is the catalysis of the reaction ATP + a phosphatidylinositol = ADP + a phosphatidylinositol phosphate, generating phosphoinositide signaling lipids.
What genes are involved in phosphatidylinositol kinase activity?
Key genes include PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIP5K1A, PIP5K1B, PIP5K1C, and regulators such as PTEN and INPP4A [1,2,8].
How is phosphatidylinositol kinase activity regulated?
It is regulated by receptor tyrosine kinases, membrane interactions, dimerization, and negative regulators like PTEN [2,4,8].
What diseases are associated with phosphatidylinositol kinase activity?
Cancer, diabetes, infectious diseases, and immune disorders are linked to dysregulated phosphatidylinositol kinase activity [1,3,6,8].
What methods are used to measure phosphatidylinositol kinase activity?
In vitro kinase assays, lipidomics, CRISPR screens, and imaging are commonly used [1,2,4].
How does insulin affect phosphatidylinositol kinase activity?
Insulin stimulates phosphatidylinositol-3-kinase activity in adipocytes and other tissues [5,7].
What is the role of PI3K in cancer?
Activating mutations in PI3K genes or loss of PTEN lead to constitutive phosphatidylinositol kinase activity, promoting tumor growth [1,8].
Can CRISPR be used to study phosphatidylinositol kinase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies.
What is the difference between PI3K and PIP5K?
PI3K phosphorylates the 3-position of phosphatidylinositol, while PIP5K phosphorylates the 5-position, producing different phosphoinositide products [1,2].
How can I model phosphatidylinositol kinase dysfunction in the lab?
EDITGENE offers custom CRISPR cell models including knockout, point mutation, and knock-in to study phosphatidylinositol kinase genes [1,2].
Conclusion
Phosphatidylinositol kinase activity (GO:0052742) is a fundamental enzymatic function that generates phosphoinositide second messengers controlling cell growth, metabolism, and survival. Its dysregulation underlies cancer, diabetes, and infections, making it a prime target for research and drug discovery [1,6,8]. CRISPR-based models provide powerful tools to dissect the precise roles of phosphatidylinositol kinases and their regulators in health and disease.
References
- 1. Kapeller R et al.. 1994. Phosphatidylinositol 3-kinase.. Bioessays 16(8):565-76 PMID: 8086005
- 2. Hansen SD et al.. 2022. Membrane-mediated dimerization potentiates PIP5K lipid kinase activity.. Elife 11 PMID: 35976097
- 3. Whitman M et al.. 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.. Nature 315(6016):239-42 PMID: 2987699
- 4. Sale GJ et al.. 1986. Characterization of phosphatidylinositol kinase activity associated with the insulin receptor.. Eur J Biochem 155(2):345-51 PMID: 3007126
- 5. Giorgetti S et al.. 1992. Insulin stimulates phosphatidylinositol-3-kinase activity in rat adipocytes.. Eur J Biochem 207(2):599-606 PMID: 1321717
- 6. Gimenez AM et al.. 2015. Phosphatidylinositol kinase activities in Trypanosoma cruzi epimastigotes.. Mol Biochem Parasitol 203(1-2):14-24 PMID: 26493613
- 7. Ruderman NB et al.. 1990. Activation of phosphatidylinositol 3-kinase by insulin.. Proc Natl Acad Sci U S A 87(4):1411-5 PMID: 2154747
- 8. Dikic I et al.. 2003. Negative receptor signalling.. Curr Opin Cell Biol 15(2):128-35 PMID: 12648667
